Press "esc" to clear
Go to Advanced Search
Showing results 6170 of 6202

Article ID: 704604

Age Alone Doesn't Increase Complications of Free-Flap Breast Reconstruction in Older Women

Wolters Kluwer Health: Lippincott Williams and Wilkins

Breast reconstruction using a "free flap" from the patient's abdomen is a safe procedure with a high success rate in older women opting for reconstruction after mastectomy, reports a study in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Released:
29-Nov-2018 10:15 AM EST

Article ID: 704584

Synthetic Cells Command New Powers of Communication

University of California San Diego

Researchers at UC San Diego used materials like clay and plastic to create synthetic cells—or “cell-mimics”—capable of gene expression and communication rivaling that of living cells. According to some scientists, these newly published research results could be among the most important in synthetic biology this year.

Released:
28-Nov-2018 3:05 PM EST
AML.jpg

Article ID: 704576

FDA Approves New Targeted Drug for Leukemia Tested at University of Pennsylvania

Perelman School of Medicine at the University of Pennsylvania

The U.S. Food and Drug Administration (FDA) has approved the first ever inhibitor drug specifically approved for treating patients with relapsed or refractory acute myeloid leukemia (AML) with a mutation in the Fms-like tyrosine kinase 3 (FLT3) gene.

Released:
28-Nov-2018 3:00 PM EST
BER-2018-11-d-lrg.jpg

Article ID: 704425

New Technology Consistently Identifies Proteins from a Dozen Cells

Department of Energy, Office of Science

A new platform melding microfluidics and robotics allows more in-depth bioanalysis with fewer cells than ever before.

Released:
28-Nov-2018 2:05 PM EST
shutterstock_736555114.jpg

Article ID: 704578

UCLA research suggests widely used breast cancer therapy doesn’t cause cognitive decline

University of California, Los Angeles (UCLA), Health Sciences

UCLA researchers have found that commonly used hormone therapies for women diagnosed with breast cancer do not appear to cause significant cognitive dysfunction following the treatment.

Released:
28-Nov-2018 2:05 PM EST
chen-james.jpg

Article ID: 704574

Scientists solve longtime mystery in innate immunity

UT Southwestern Medical Center

Scientists have long wondered how one protein, NLRP3, can promote inflammation in response to a wide range of seemingly unrelated stimuli.

Released:
28-Nov-2018 2:05 PM EST

Article ID: 704565

Single cell sequencing sheds light on why cancers form in specific cell types

University of Illinois at Chicago

While many cells in our bodies can accumulate oncogenic mutations, the majority of these events do not lead to tumor formation as these abnormal cells are eliminated by defense mechanisms. Instead, tumors arise when a mutation happens in a particular cell type that is uniquely sensitive to it. Identifying such cancer cells of origin is essential to properly target cancer.

Released:
28-Nov-2018 1:05 PM EST

Article ID: 704558

Antibiotic could protect against neurodegenerative diseases during aging

eLife

An antibiotic, minocycline, can increase the lifespan of roundworms by preventing the build-up of proteins during aging, a study in the open-access journal eLife reports.

Released:
28-Nov-2018 1:00 PM EST

Article ID: 704547

Predators drive Nemo's relationship with an unlikely friend

University of Queensland

Predators have been identified as the shaping force behind mutually beneficial relationships between species such as clownfish and anemones. The finding results from a University of Queensland and Deakin University-led study.

Released:
28-Nov-2018 12:15 PM EST
FenstermakerandCiesielskiLab2012-08-2133.jpg

Article ID: 704536

Brain Cancer Immunotherapy SurVaxM Extends Survival, Even in Hard-to-Treat Patients

Roswell Park Comprehensive Cancer Center

The latest results from an ongoing clinical study incorporating the immunotherapy SurVaxM as part of combination treatment for glioblastoma show that this investigational drug is safe, well-tolerated and extended survival even among the hardest-to-treat subgroups of patients. The findings were presented at the Society for Neuro-Oncology Annual Meeting in New Orleans.

Released:
28-Nov-2018 11:05 AM EST

Showing results 6170 of 6202

Chat now!